Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Haematologica|November 20, 2023
Pilot study of lung cancer screening for survivors of Hodgkin lymphomaRachel Broadbent, Philip Crosbie, Christopher J Armitage, et al.
Journal of Clinical Pathology|November 27, 2010
YY1 expression predicts favourable outcome in follicular lymphomaKhimara Naidoo, Vanessa Clay, Judith A Hoyland, et al.
Cardio-Oncology (London, England)|May 12, 2026
SWATH-MS for discovery of early biomarkers of drug-induced cardiotoxicity using an animal doxorubicin modelRohan Shotton, Amy Campbell, Ivona Baricevic-Jones, et al.
The Journal of Molecular Diagnostics : JMD|March 27, 2012
Microarray gene expression analysis of fixed archival tissue permits molecular classification and identification of potential therapeutic targets in diffuse large B-cell lymphomaKim Linton, Christopher Howarth, Mark Wappett, et al.
Journal of Clinical Pathology|June 13, 2013
PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcomeHarriet E Sandison, Suzanne Usher, Ehsan G Karimiani, et al.
Contraception|June 14, 2017
A phase I randomized postcoital testing and safety study of the Caya diaphragm used with 3% Nonoxynol-9 gel, ContraGel or no gelChristine K Mauck, Vivian Brache, Thomas Kimble, et al.
Cancer Immunology, Immunotherapy : CII|April 30, 2021
Immune infiltrate diversity confers a good prognosis in follicular lymphomaAnna-Maria Tsakiroglou, Susan Astley, Manàs Dave, et al.
British Journal of Cancer|December 7, 2019
Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinomaAnna Maria Tsakiroglou, Martin Fergie, Ken Oguejiofor, et al.
BMC Medical Research Methodology|May 3, 2025
The REFRACT trial: implementation of Bayesian power priors in a randomised, sequential phase II adaptive platform trialCharlotte Gaskell, Kim Linton, Mark Bishton, et al.
Oncoimmunology|July 8, 2026
Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphomaLorenzo Falchi, Martin Hutchings, David Tybor, et al.
Pageof 5